SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-023567
Filing Date
2020-02-21
Accepted
2020-02-20 21:50:10
Documents
6
Period of Report
2020-02-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm209375-4_8k.htm 8-K 29226
2 EXHIBIT 1.1 tm209375d4_ex1-1.htm EX-1.1 242827
3 EXHIBIT 5.1 tm209375d4_ex5-1.htm EX-5.1 16006
4 EXHIBIT 10.1 tm209375d4_ex10-1.htm EX-10.1 54534
5 GRAPHIC tm209375d1_ex5-1img01.jpg GRAPHIC 5224
6 GRAPHIC tm209375d1_ex5-1img02.jpg GRAPHIC 3008
  Complete submission text file 0001104659-20-023567.txt   355348
Mailing Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511
Business Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511 203-643-8060
BioXcel Therapeutics, Inc. (Filer) CIK: 0001720893 (see all company filings)

IRS No.: 821386754 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38410 | Film No.: 20637257
SIC: 2834 Pharmaceutical Preparations